"We note that the press release from February 12th

"We note that the press release from February 12th, 2015 is a very interesting development for VeriTeQ Corp. Essentially, the term sheet the company has executed gives Establishment Labs, S.A. "EL" the option to exclusively license VeriTeQ's intellectual property, safety data test and FDA file reference, and business opportunities related to its Q Inside Safety Technology for the breast implant market for an upfront license fee of $1.75 million with a 24-month option to purchase VeriTeQ's Q Inside Safety Technology business for the breast implant market for $10 million, minus the license fee.